CA
Craig Adam R
董事长兼首席执行官
C-suiteM
内部人交易记录
首席执行官基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the detailed record of transactions filed by Craig Adam R, 董事长兼首席执行官. Director active across 2 companies, notably CTI Biopharma CORP. Cumulatively, 13 disclosures have been recorded. Split: 2 buys · 1 sell. Total volume traded: €425k. Activity tracked since 30 June 2021. The latest transaction was filed on 12 August 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Craig Adam R
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报13 总计
47,436 股@ US$4.44450.050% mcap45.9% 占其流量Common StockSEC:0001501697-26-000069:0
86,206 股@ US$2.90100.0% 占其流量Common StockSEC:0001501697-25-000035:0
289,881 股0Common StockSEC:0001628280-25-040441:0
31,470 股@ US$9.1039.3% 占其流量Common StockSEC:0000899243-23-016480:0
83,200 股@ US$0.84119.6% 占其流量common stockSEC:0000891293-23-000004:0
13,800 股@ US$0.84111.6% 占其流量common stockSEC:0000891293-23-000002:0
53,996 股@ US$0.84116.7% 占其流量common stockSEC:0000891293-22-000056:0
242,300 股@ US$0.841130.1% 占其流量Common StockSEC:0000899243-22-031043:0
5,000 股@ US$5.504.0% 占其流量common stockSEC:0000891293-22-000044:0
6,183 股@ US$2.11651.9% 占其流量common stockSEC:0000891293-22-000034:0
27,000 股@ US$0.84113.2% 占其流量common stockSEC:0000891293-22-000027:0
3,178 股@ US$2.1080.9% 占其流量Common StockSEC:0000899243-22-010768:0
5,000 股@ US$2.1251.4% 占其流量common stockSEC:0000891293-21-000045:0
About Craig Adam R
Craig Adam R is President and CEO. He has 12 filings in total. In the 12 most recent filings, the reported buy volume is EUR 242219, the reported sell volume is EUR 0, and the date range runs from 2021-12-02 to 2025-10-27. The most frequent transaction nature is Option exercise.